Oxaliplatin, Capecitabine
Sponsors
University of Southern California, Royal Marsden NHS Foundation Trust, University of Louisville, Sanofi, AIO-Studien-gGmbH
Conditions
Colorectal NeoplasmsEsophageal CancerGastric CancerHead or Neck CancerRectal CancerRectal Neoplasms
Phase 2
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
CompletedNCT00183898
Start: 2004-12-28End: 2020-06-19Updated: 2026-07-30
A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer
CompletedNCT00220051
Start: 2001-11-30Updated: 2013-05-31
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
CompletedNCT00266279
Start: 2005-04-30End: 2009-10-31Updated: 2020-09-03
Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer
CompletedNCT00421824
Start: 2006-05-31End: 2010-11-30Updated: 2011-01-04
Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer
TerminatedNCT00950820
Start: 2009-09-30End: 2012-03-31Updated: 2013-03-04